Last reviewed · How we verify
NCT06629493
Feasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder
NA trial testing Fitbit Versa 3 in Substance-Related Disorders in 90 participants. Completed in 2 July 2025.
1 July 2025
Quick facts
| Lead sponsor | University of Oviedo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 4 April 2022 |
| Primary completion | 1 July 2025 |
| Estimated completion | 2 July 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Fitbit Versa 3
- In-patient alcohol use disorder treatment
Conditions studied
- Substance-Related Disorders — all drugs for Substance-Related Disorders →
- Alcohol-Related Disorders — all drugs for Alcohol-Related Disorders →
- Alcohol Use Disorder (AUD) — all drugs for Alcohol Use Disorder (AUD) →
Sponsor
University of Oviedo
Who can join
18 and older, any sex, with Substance-Related Disorders or Alcohol-Related Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective is to assess the feasibility and effectiveness of using activity trackers to increase physical activity and improve the emotional state of people receiving an in-patient treatment for alcohol use disorder
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06629493
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fitbit Versa 3
Trials testing the same drug.
- NCT06629467 — Cognitive Behavioral Treatment with Activity Trackers for Smoking Cessation · NA · recruiting
Other recruiting trials for Substance-Related Disorders
Currently open trials in the same condition.
- NCT06676059 — SMART-r: Substance Monitoring and Active Relapse Tracking Repository · recruiting
- NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
- NCT06387290 — Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits · Phase 3 · recruiting
- NCT05763537 — Understanding the Role of Doulas in Supporting People With PMADs · NA · recruiting
- NCT06685003 — Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families · NA · recruiting
Other University of Oviedo trials
Trials by the same sponsor.
- NCT07419386 — Clinical and Psychosocial Factors Associated With Physical Activity Level in Adults With Marfan Syndrome · not yet recruiting
- NCT07408765 — Physical Activity, Fatigue, Social Support, and Psychological Well-Being in Women With Primary Hypothyroidism · recruiting
- NCT07406802 — Association Between Racket Stiffness and Lateral Epicondylalgia in Tennis Players · recruiting
- NCT07408700 — Influence of Training Surface and Mechanical Load on the Prevalence of Patellofemoral Pain in Recreational Runners · recruiting
- NCT07408739 — Association Between Weekly Strength Training Load and Perceived Physical Performance in Non-Professional Soccer Players · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06629493 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oviedo
- Last refreshed: 22 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06629493.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing